Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia

Meaghan M. Broman, Nadia A. Lanman, Renee E. Vickman, Gregory M. Cresswell, Harish Kothandaraman, Andree K. Kolliegbo, Sebastian Juan Paez, Alexander P. Glaser, Brian T. Helfand, Gervaise H. Henry, Douglas W. Strand, Omar E. Franco, Susan E. Crawford, Simon W. Hayward, Timothy L. RatliffbioRxiv 2024 · DOI

TL;DR

This study identifies a specific type of aging T cell, characterized by high Granzyme K (GZMK) and low Granzyme B (GZMB) expression (dubbed "Taa" cells), that infiltrates aged prostates and correlates with the severity of benign prostatic hyperplasia (BPH) symptoms. These Taa cells appear to promote inflammation by stimulating prostate fibroblasts to release inflammatory molecules, linking immune aging to BPH.

What Problem Does This Paper Address?

Benign prostatic hyperplasia (BPH) is a common age-related condition affecting a significant portion of older men, leading to bothersome lower urinary tract symptoms (LUTS). While inflammation is known to be involved in BPH, the specific role of age-related changes in the immune system, particularly in T cells, has not been well understood. This paper aims to bridge that gap by investigating how immune cell populations, and specifically T cells, change with age in the prostate and how these changes might contribute to the development and symptoms of BPH.

Methods

The researchers employed single-cell RNA sequencing (scRNA-Seq) to analyze immune cells from both young, healthy prostates and aged prostates from BPH patients (categorized as "small" and "large" based on size). They used unsupervised clustering to identify distinct immune cell subtypes and compared their proportions and gene expression profiles between different groups. To understand cell differentiation trajectories, they utilized RNA velocity analysis. Additionally, they performed in vitro experiments where they treated prostate fibroblasts with granzyme K (a protein highly expressed by the identified Taa cells) to assess its impact on the production of senescence-associated secretory phenotype (SASP) cytokines.

Datasets

The study utilized scRNA-Seq data from:

  • 3 normal young prostates.
  • 13 aged prostates from BPH patients (10 small, 10 large).
  • Previously published scRNA-seq data from 5 large BPH prostates for stromal cell analysis.
  • Data from rheumatoid arthritis (RA) patient synovium for comparative analysis of T cell subsets.

Key Insights and Ideas

  • A specific aging T cell subset is implicated in BPH: The discovery of the "Taa" CD8+ T cell subset, characterized by high GZMK and low GZMB, is a central finding. This subset is enriched in aged prostates and its presence correlates with BPH symptom severity.
  • Immune aging drives prostate inflammation: The study suggests that Taa cells contribute to a pro-inflammatory microenvironment in the prostate, linking general immune aging processes to a specific disease.
  • Granzyme K as a key mediator: Granzyme K, highly expressed by Taa cells, appears to be a crucial molecule that stimulates prostate fibroblasts to produce inflammatory SASP cytokines, potentially recruiting more immune cells and exacerbating inflammation.
  • Altered T cell differentiation in BPH: RNA velocity analysis revealed that T cell differentiation pathways are altered in larger BPH prostates, favoring the accumulation of these Taa cells.

Key Results

  • An age-associated CD8+ T cell subset (Taa) with high GZMK and low GZMB expression was found to infiltrate aged human prostates.
  • The proportion of Taa cells positively correlated with the International Prostate Symptom Score (IPSS), indicating a link to symptom severity.
  • RNA velocity analysis showed altered CD8+ T cell differentiation in large BPH prostates, favoring Taa accumulation.
  • In vitro treatment of BPH patient-derived fibroblasts with granzyme K significantly increased the secretion of pro-inflammatory SASP cytokines (IL-6, CXCL8, CCL5, CCL2, CXCL1).
  • Taa cells share a gene expression profile with GZMK-expressing T cells found in rheumatoid arthritis, suggesting a common pro-inflammatory immune mechanism.

Limitations and Future Work

  • Causality: While the study shows strong correlations, it doesn't definitively prove that Taa cells cause BPH or its symptoms. Further studies are needed to confirm a direct causal role for Taa cells in BPH development and progression.
  • Other T cell subsets: The study focused on CD8+ T cells, but other T cell subsets were also correlated with IPSS and prostate volume. Future work should investigate these as well.
  • Mechanisms of differentiation: The underlying mechanisms for the altered T cell differentiation and gene expression need further exploration.
  • Clinical consequences: The clinical consequences of these observed alterations in T cells require more investigation.
  • Stromal cell interactions: While stromal cells were analyzed, further studies are needed to confirm a direct fibroblast stimulatory capacity for Taa cells.
  • PCa tumor effects: The study used prostate tissues from PCa patients for some analyses, and while field effects are considered limited, the potential influence of tumor cells on TZ immune cells cannot be completely ruled out.
  • Normal prostate immune cells: The number of normal prostate immune cells available for analysis was limited compared to BPH specimens, which may have affected some analyses.

Summary updated

Abstract

Benign prostatic hyperplasia (BPH) is among the most common age-associated diseases in men; however, the contribution of age-related changes in immune cells to BPH is not clear. The current study determined that an age-associated CD8 <sup>+</sup> T cell subset (Taa) with high Granzyme K ( <i>GZMK <sup>hi</sup></i> ) and low Granzyme B ( <i>GZMB <sup>low</sup></i> ) gene expression infiltrate aged human prostates and positively correlate with International Prostate Symptom Score (IPSS). A velocity analysis indicated that CD8 <sup>+</sup> T cell differentiation is altered in large BPH prostates compared to small age-matched prostates, favoring Taa accumulation. In vitro granzyme K treatment of human BPH patient-derived large prostate fibroblasts increased secretion of pro-inflammatory senescence-associated secretory phenotype (SASP)-associated cytokines. These data suggest that granzyme K-mediated stimulation of prostate stromal fibroblast SASP cytokine and chemokine production promotes prostate immune cell recruitment and activation. Overall, these results connect symptomatic BPH with immune aging.
BibTeX
@misc{broman2024immune,
  author = {Meaghan M. Broman and Nadia A. Lanman and Renee E. Vickman and Gregory M. Cresswell and Harish Kothandaraman and Andree K. Kolliegbo and Sebastian Juan Paez and Alexander P. Glaser and Brian T. Helfand and Gervaise H. Henry and Douglas W. Strand and Omar E. Franco and Susan E. Crawford and Simon W. Hayward and Timothy L. Ratliff},
  title = {{Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia}},
  year = {2024},
  doi = {10.1101/2024.12.30.629739},
  howpublished = {bioRxiv},
}
Figure